Software Healthcare Sector

Mesoblast

Market Cap: AU$3.0b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Aveanna Healthcare Holdings

Market Cap: US$2.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Axogen

Market Cap: US$2.1b

Engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.

Surgery Partners

Market Cap: US$2.1b

Owns and operates a network of surgical facilities and ancillary services in the United States.

Pediatrix Medical Group

Market Cap: US$2.1b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Omnicell

Market Cap: US$2.1b

Provides healthcare technology in the United States and internationally.

Aurinia Pharmaceuticals

Market Cap: US$2.1b

A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.

CareDx

Market Cap: US$2.1b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Viridian Therapeutics

Market Cap: US$2.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Addus HomeCare

Market Cap: US$2.0b

Provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.

Rapport Therapeutics

Market Cap: US$2.0b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

agilon health

Market Cap: US$2.0b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

Damora Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America.

ADMA Biologics

Market Cap: US$2.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Astrana Health

Market Cap: US$2.0b

A healthcare management company, provides medical care services in the United States.

Pulse Biosciences

Market Cap: US$2.0b

Operates as a novel bioelectric medicine company.

HUTCHMED (China)

Market Cap: UK£1.5b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Monte Rosa Therapeutics

Market Cap: US$2.0b

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Syndax Pharmaceuticals

Market Cap: US$2.0b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

GH Research

Market Cap: US$2.0b

Together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.

Ocular Therapeutix

Market Cap: US$2.0b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

UroGen Pharma

Market Cap: US$2.0b

A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.

Harmony Biosciences Holdings

Market Cap: US$2.0b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States.

Amylyx Pharmaceuticals

Market Cap: US$1.9b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Zenas BioPharma

Market Cap: US$1.9b

A clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

Genus

Market Cap: UK£1.4b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

UFP Technologies

Market Cap: US$1.9b

Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

Sonida Senior Living

Market Cap: US$1.9b

Owns and operates senior housing communities in the United States.

Kardigan

Market Cap: US$1.9b

Operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.

NeoGenomics

Market Cap: US$1.9b

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Tyra Biosciences

Market Cap: US$1.8b

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

NovoCure

Market Cap: US$1.8b

An oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.

Bicara Therapeutics

Market Cap: US$1.8b

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Sienna Senior Living

Market Cap: CA$2.6b

Provides senior living services in Canada.

Precigen

Market Cap: US$1.8b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Maravai LifeSciences Holdings

Market Cap: US$1.8b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.